TABLE 1 Summary of Reports on HPV Infection in Oral Mucosaa

From: “High Risk” HPV Types Are Frequently Detected in Potentially Malignant and Malignant Oral Lesions, But Not in Normal Oral Mucosa

Study

References

Country

Year

Normal Samples

Pathologic Specimens

HPV Positive

Infection by Typesb

Detection Methods

     

Hyperpl

Dyspl

Oral SqCC

 

2

6

11

16

18

33

58

Otherc

SB

PCR

DB

ISH

RFLP

SEQ

IHC

EM

North America

                        

 Holladay & Gerald

10

USA

1993

6 (17%)

9 (44%)

36 (25%)

39 (18%)

20 (24%)

 

11

 

21

1

   

+

+

      

 Woods et al.

11

USA

1993

9 (67%)

18 (78%)

14 (78%)

 

4

1

7

2

    

+

      

 Brandwein et al.

12

USA

1994

64 (25%)

16 (25%)

         

+

      

 Paz et al.

13

USA

1997

92 (20%)

18 (20%)

 

2

 

13

   

3

+

+

      

 Portugal et al.

14

USA

1997

58 (7%)

4 (7%)

         

+

      

 Wilczynski et al.

15

USA

1998

19 (63%)

12 (63%)

   

9

 

1

 

2

+

+

 

+

+

   

South America

                        

 Miguel et al.

16

Brazil

1998

34 (12%)

34 (12%)

4 (12%)

   

4

     

+

+

+

    

 Premoli-De-Percoco et al.

8

Venezuela

1998

50 (70%)

35 (70%)

 

7

 

28

       

+

    

Africa

                        

 Van Rensburg et al.

17

South Africa

1995

66 (0%)

0 (0%)

           

+

  

+

 

Asia

                        

 Chang et al.

18

China

1989

17 (6%)

3 (100%)

17 (76%)

16 (80%)

   

16

    

+

       

 Heinzel et al.

19

India

1996

91 (74%)

67 (74%)

                

 Chatterjee et al.

20

India

1997

39 (69%)

26 (69%)

   

19

       

+

    

 D'Costa et al.

3

India

1998

48 (31%)

80 (34%)

100 (15%)

42 (23%)

   

42

    

+

+

      

 Wen et al.

21

Japan

1997

15 (33%)

45 (33%)

16 (32%)

   

16

12

   

+

+

   

+

  

 Mineta et al.

22

Japan

1998

14 (21%)

3 (21%)

   

3

     

+

      

 Shinji et al.

23

Japan

1999

7 (0%)

15 (0%)

0 (0%)

        

+

+

      

 Koh et al.

24

Korea

1998

42 (52%)

22 (52%)

   

13

5

4

  

+

+

      

Europe

                        

 Cerovac et al.

25

Croatia

1996

25 (20%)

5 (20%)

           

+

    

 Eike et al.

26

Denmark

1995

61 (0%)

         

+

      

 Syrjanen et al.

27

Finland

1983

40 (40%)

16 (40%)

              

+

+

 Atula et al.

28

Finland

1997

41 (20%)

8 (20%)

   

4

    

+

+

      

 Fouret et al.

29

France

1995

42 (0%)

3 (0%)

21 (8%)

2 (8%)

        

+

+

      

 Gassenmaier & Hornstein

30

Germany

1988

202 (10%)

103 (18%)

68 (24%)

56 (15%)

4

6

7

12

       

+

    

 Honig

31

Germany

1992

12 (60%)

7 (60%)

           

+

    

 Ostwald et al.

32

Germany

1994

97 (1%)

26 (61.5%)

16 (61.5%)

        

+

+

      

 Arndt et al.

33

Germany

1997

14 (86%)

1 (100%)

13 (87%)

 

13

 

3

    

+

+

      

 Riethdorf et al.

34

Germany

1997

80 (44%)

35 (44%)

         

+

+

     

 Andl et al.

35

Germany

1998

64 (17%)

11 (17%)

   

8

 

1

  

+

+

      

 Lambropoulos et al.

36

Greece

1997

169 (9.5%)

 

7

1

4

    

+

+

      

 Present study

 

Greece

1999

16 (0%)

29 (86%)

5 (100%)

19 (95%)

48 (90%)

 

7

1

34

17

6

3

  

+

+

+

+

   

 Lo Muzio et al.

37

Italy

1997

21 (48%)

5 (40%)

17 (66%)

 

3

 

9

       

+

    

 Cruz et al.

38

Netherlands

1996

35 (54%)

19 (54%)

 

1

 

15

   

4

+

+

      

 Snijders et al.

39

Netherlands

1996

25 (20%)

5 (20%)

   

5

    

+

+

      

 Matzow et al.

40

Norway

1998

5 (0%)

35 (3%)

1 (3%)

       

1

 

+

      

 Adams et al.

41

Switzerland

1999

4 (50%)

20 (30%)

6 (30%)

   

5

1

    

+

  

+

   

 Jalal et al.

42

UK

1992

48 (44%)

   

21

     

+

      

 Scholes et al.

43

UK

1997

8 (62%)

5 (62%)

   

5

    

+

+

      

 Elamin et al.

44

UK

1998

12 (33%)

28 (50%)

18 (45%)

 

8

 

10

     

+

      

 Penhallow et al.

45

UK

1998

3 (67%)

9 (56%)

28 (50%)

18 (53%)

 

8

 

10

     

+

      
  1. HPV, human papillomavirus; Hyperpl, hyperplasia; Dyspl, dysplasia; SqCC, squamous cell carcinoma; SB, Southern or slot blot; PCR, polymerase chain reaction; DB, dot blot; ISH, in situ hybridization; RFLP, restriction fragment length polymorphism; SEQ, sequencing; IHC, immunohistochemistry; EM, electron microscopy.
  2. aStudies analyzing fewer than 10 samples were not included in this table.
  3. bDetected either alone or in combination with other types.
  4. cType determination not achieved by applied methodology.